NOLDUS INFORMATION TECHNOLOGY BV

Their core work

Noldus is a Dutch SME that develops software and hardware systems for measuring and analyzing behavior — in humans, animals, and their interactions. Their tools (including video tracking, facial expression analysis, and physiological measurement platforms) are used across clinical research, animal welfare studies, and consumer science. In H2020 projects, they serve as the technology provider that supplies behavioral observation and measurement infrastructure to large research consortia, translating complex behavioral data into quantifiable outcomes.

What they specialise in

How they've shifted over time

In their early H2020 period (2015–2018), Noldus contributed behavioral measurement tools across diverse domains — veterinary biosafety infrastructure (VetBioNet), livestock genomics (GenTORE), assisted living (ACROSSING, eNHANCE), and preclinical data quality (EQIPD). From 2018 onward, their focus shifted decisively toward neurodevelopmental research, with projects on autism biomarkers (AIMS-2-TRIALS), comorbid neurological conditions (CANDY), and poultry welfare (CHICKENSTRESS), while also expanding into food consumer science (COMFOCUS, Code Re-farm). The trend shows a concentration from broadly applied behavioral technology toward clinical neuroscience and food system applications.

Noldus is deepening its clinical neuroscience capabilities — partners seeking behavioral biomarker measurement tools for autism, ADHD, or epilepsy research will find an experienced technology provider here.

How they like to work

Noldus never coordinates — they join as a specialist participant or third party providing behavioral measurement technology to large consortia. With 212 unique partners across 27 countries, they operate as a widely connected but non-leading technology supplier, bringing their commercial tools into research settings. This makes them a low-friction partner: they know how to integrate into diverse teams, deliver defined technology components, and do not compete for scientific leadership.

Exceptionally broad network of 212 unique consortium partners spanning 27 countries, built through participation in large-scale RIA and IMI projects. Their connections are pan-European with no single geographic concentration, reflecting their role as a commercial tool provider welcomed into consortia across disciplines.

What sets them apart

Noldus occupies a rare niche as a commercial SME whose core product — behavioral measurement software and hardware — is directly useful across multiple research domains, from clinical neuroscience to animal welfare to consumer studies. Unlike academic partners who bring domain expertise, Noldus brings a mature, commercially supported technology platform that consortia can deploy immediately. Their Wageningen base places them at the heart of the Netherlands' agricultural and life sciences ecosystem, adding credibility in both food and health sectors.

Highlights from their portfolio

• AIMS-2-TRIALS
  Largest IMI2 autism research initiative in Europe with a long timeline (2018–2026), focusing on biomarkers and clinical outcome measures where Noldus behavioral tools are central.
• Code Re-farm
  Their highest single-project EC funding (€322,438) and most recent project, signaling a strategic move into consumer-driven food systems.
• GenTORE
  Major precision livestock project (€311,875 EC funding) connecting Noldus behavioral monitoring technology to genomic management of cattle resilience and efficiency.